van Es-Johansson An — SEC Form 4 filings
SEC reporting owner CIK 1795902. 10 Form 4 filings on record with FilingPulse; latest filed 2026-07-01.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-02-26 to 2026-07-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PLUS THERAPEUTICS, INC. (PSTV) | Director | 6 | — | — | 8 |
| LUMOS PHARMA, INC. | Director | 2 | — | — | 7 |
| Savara Inc (SVRA) | Director | 2 | — | — | 2 |
Form 4 filings — van Es-Johansson An
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-01 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Option exercise (M): 922 @ $0 · Option exercise (M): 922 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 3,686 (derivative) @ $0 · Grant/award (A): 3,686 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | Savara Inc (SVRA) | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2025-08-15 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 297,794 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 40,122 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | Savara Inc (SVRA) | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2024-12-13 | 4 | LUMOS PHARMA, INC. | Disposition to issuer (D): 1,100 · Disposition to issuer (D): 3,345 (derivative) · Disposition to issuer (D): 3,328 (derivative) · Disposition to issuer (D): 3,431 (derivative) · Disposition to issuer (D): 2,910 (derivative) · Disposition to issuer (D): 5,729 (derivative) | EDGAR |
| 2024-09-12 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 3,650 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | LUMOS PHARMA, INC. | Grant/award (A): 3,328 (derivative) @ $0 | EDGAR |
| 2024-02-26 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 2,250 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1795902 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →